Moderna Statistics
Share Statistics
Moderna has 386.74M
shares outstanding. The number of shares has increased by 0.67%
in one year.
| Shares Outstanding | 386.74M |
| Shares Change (YoY) | 0.67% |
| Shares Change (QoQ) | 0.26% |
| Owned by Institutions (%) | 72.04% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 903 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 60.22M, so 15.58% of the outstanding
shares have been sold short.
| Short Interest | 60.22M |
| Short % of Shares Out | 15.58% |
| Short % of Float | 21.63% |
| Short Ratio (days to cover) | 9.55 |
Valuation Ratios
The PE ratio is -4.48 and the forward
PE ratio is -3.03.
Moderna's PEG ratio is
0.18.
| PE Ratio | -4.48 |
| Forward PE | -3.03 |
| PS Ratio | 4.93 |
| Forward PS | 1.4 |
| PB Ratio | 1.46 |
| P/FCF Ratio | -3.94 |
| PEG Ratio | 0.18 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Moderna.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.67,
with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.67 |
| Quick Ratio | 3.62 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.22 |
| Debt / FCF | -0.18 |
| Interest Coverage | -164.38 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $557,931.03 |
| Profits Per Employee | $-613,965.52 |
| Employee Count | 5,800 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 12.51 |
Taxes
| Income Tax | -46M |
| Effective Tax Rate | 1.28% |
Stock Price Statistics
The stock price has increased by -81.32% in the
last 52 weeks. The beta is 2, so Moderna's
price volatility has been higher than the market average.
| Beta | 2 |
| 52-Week Price Change | -81.32% |
| 50-Day Moving Average | 28.46 |
| 200-Day Moving Average | 47 |
| Relative Strength Index (RSI) | 43.97 |
| Average Volume (20 Days) | 11,487,672 |
Income Statement
In the last 12 months, Moderna had revenue of 3.24B
and earned -3.56B
in profits. Earnings per share was -9.27.
| Revenue | 3.24B |
| Gross Profit | 1.77B |
| Operating Income | -3.94B |
| Net Income | -3.56B |
| EBITDA | -3.39B |
| EBIT | -3.58B |
| Earnings Per Share (EPS) | -9.27 |
Full Income StatementBalance Sheet
The company has 1.93B in cash and 747M in
debt, giving a net cash position of 1.18B.
| Cash & Cash Equivalents | 1.93B |
| Total Debt | 747M |
| Net Cash | 1.18B |
| Retained Earnings | 10.04B |
| Total Assets | 12.7B |
| Working Capital | 5.16B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -3B
and capital expenditures -1.05B, giving a free cash flow of -4.05B.
| Operating Cash Flow | -3B |
| Capital Expenditures | -1.05B |
| Free Cash Flow | -4.05B |
| FCF Per Share | -10.56 |
Full Cash Flow StatementMargins
Gross margin is 54.76%, with operating and profit margins of -121.91% and -110.04%.
| Gross Margin | 54.76% |
| Operating Margin | -121.91% |
| Pretax Margin | -111.46% |
| Profit Margin | -110.04% |
| EBITDA Margin | -104.88% |
| EBIT Margin | -121.91% |
| FCF Margin | -125.31% |
